2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone with CAS No:32384-65-9 is an impurity standard of Empagliflozin.
Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, is employed for the management of type 2 diabetes mellitus. By inhibiting SGLT2 in the kidneys, empagliflozin enhances the excretion of glucose in urine, leading to a reduction in blood glucose levels. Beyond its glucose-lowering effects, clinical studies have indicated cardiovascular benefits, demonstrating a reduction in cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease. As part of a comprehensive diabetes management plan, empagliflozin is prescribed under the guidance of healthcare professionals, often complementing lifestyle modifications and other medications to optimize overall diabetes care.
Buy high quality 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone from from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone